(Q70560932)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Occurrence of second tumors in man after anticancer drug treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1

D Schmähl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

M Habs

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

M Lorenz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

I Wagner

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 September 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

167-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

Acute myeloid leukaemia after treatment with cytostatic agents

12 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Carcinoma of the Bladder complicating Cyclophosphamide Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukaemia after prolonged chlorambucil treatment for non-malignant disease: report of a new case and literature survey

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

The effects of cyclophosphamide treatment on the epithelium and stroma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukemia in multiple myeloma: case histories, a review of the literature and assessment of the incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute nonlymphocytic leukemia.A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute myeloid leukaemia in the course of Hodgkin's disease (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Osteosarcoma and acute myeloblastic leukemia after therapy for childhood Hodgkin disease - a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Transitional cell carcinoma of the bladder associated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukemia complicating metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Leukaemia after prolonged use of melphalan for non-malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Bladder cancer following administration of cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Extraosseous lesions in plasma cell myeloma. A report of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

The Incidence Of Bladder Cancer after Cyclophosphamide Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute erythromegakaryocytic leukaemia after treatment with cytostatic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Bladder cancer after cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute myeloblastic leukemia after cure of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

[Long term treatment of multiple myeloma]

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukemia following anticancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Pancreatic carcinoma as a sequel to therapy of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute Myelogenous Leukemia Following ImmunosuppressiveTherapy for Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Induced acute non-lymphocytic leukemia following long-term chemotherapy: a study of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Alkylating agents as leukemogens in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute Leukemia Following Cytotoxic Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Lymphoreticular hyperplasia in a case of psoriasis treated with methotrexate for three years

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute Erythroleukemia Complicating Prolonged Chemotherapy for Ovarian Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Interstitial pulmonary fibrosis, atypical epithelial changes and bronchiolar cell carcinoma following busulfan therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Multiple myeloma and acute myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Multiple myeloma and acute leukemia associated with alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Multiple myeloma and terminal acute myeloid leukaemia (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Cancer of the Bladder in Patients Treated with Chlornaphazine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Squamous cell carcinoma of the tongue in a nine year renal transplant survivor.A case report with a discussion of the risk of development of epithelial carcinomas in renal transplant survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Transformation of reticulum cell sarcoma to acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Premalignant and malignant skin tumours in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute Leukemia following Combination Chemotherapy for Cancer of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Adenocarcinoma of the lung during azathioprine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for nonmalignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Ultrastructural characteristics of therapy-related acute nonlymphocytic leukemia: evidence for a panmyelosis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Cyclophosphamide and pure squamous-cell carcinoma of the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Chronic granulocytic leukemia in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Cytogenetic studies of bone marrow in breast cancer patients after adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Monocytic and monomyelocytic leukaemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Does cyclophosphamide induce bladder cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukemia following cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Erythroleukaemia in a Melphalan-Treated Patient with Primary Macroglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Cyclophosphamide and bladder carcinoma (case report) (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Rapid development of keratoaganthoma and accelerated transformation into squamous cell carcinoma of the skin.A mutagenic effect of polychemotherapy in a patient with hodgkin's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Letter: Urinary-bladder tumors after cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukaemia after immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Letter: Androgen role in erythroleukemia after treatment with alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

[Fibrosarcoma of the bladder after seven-year chemotherapy of Hodgkin's disease in childhood]

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukemia in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Carcinoma of the Bladder With Azathioprine Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Carcinogenic action of low-dose cyclophosphamide given orally to sprague-dawley rats in a lifetime experiment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Plasmocytoma, alkylating agents, and acute myeloid leukemia (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute nonlymphocytic leukemia in patients receiving chemotherapy for nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute myeloid leukaemia after treatment with cytostatic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukaemia after busulphan

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Acute leukemia complicating treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Carcinoma of the Urinary Bladder in Patients Receiving Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980006-6

7 January 2021

10.1016/S0305-7372(82)80006-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7159878%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference